Acadia Healthcare price target lowered to $33 from $40 at BofA

BofA lowered the firm’s price target on Acadia Healthcare (ACHC) to $33 from $40 and keeps a Buy rating on the shares. Q1 EBITDA was 2% above consensus and 1% above the firm’s estimates, notes the analyst, who largely maintains the firm’s adjusted EBITDA estimates, but cut the firm’s price target on a lower peer multiple.